|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue, net | |||||
| Patient services revenue | |||||
| Services | |||||
| Products | |||||
| Other | |||||
| Total revenue, net | |||||
| Cost of sales | |||||
| Labor | |||||
| Occupancy | |||||
| Products and other operating costs | |||||
| Total cost of sales | |||||
| Gross Profit | |||||
| Depreciation and amortization | |||||
| Impairment of long-lived assets | |||||
| Goodwill impairment | |||||
| Loss on disposal of assets, net | |||||
| Impairment of operating lease right-of-use assets | |||||
| General and administrative | |||||
| Salaries and Benefits | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Change in fair value of derivative liabilities | |||||
| Change in fair value of warrant liability | |||||
| Loss on issuance of Series G Preferred Stock | |||||
| Interest income, net | |||||
| Foreign exchange loss | |||||
| Gain on securities, realized and unrealized | |||||
| Gain on investments, realized and unrealized | |||||
| Other non-operating expense, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Total net loss | |||||
| Other comprehensive income (loss) from operations | |||||
| Foreign currency translation | |||||
| Comprehensive loss | |||||
| Loss per share | |||||
| Preferred stock dividends | |||||
| Preferred stock accretion | |||||
| Less: deemed dividend on warrant exchange | |||||
| Less: deemed dividend on Exchange of Series G Preferred Stock | |||||
| Net loss attributable to XWELL, Inc. common stockholders | |||||
| Basic loss per share (in dollars per share) | |||||
| Diluted loss per share (in dollars per share) | |||||
| Weighted-average number of shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Net loss attributable to noncontrolling interests | |||||
| Net loss attributable to XWELL, Inc. | |||||
Loading...